Skip to content

Released Aug 5, 2014

10-Q filed Aug 5, 2014, 36 days after period end · 0001104659-14-056936

Q2 2014 · 10-Q
Revenue$6.84M−29.2% vs Q2 2013−53.2% vs Q1 2014
Net income—
EPS Diluted-$0.44N/M vs Q2 2013N/M vs Q1 2014
Operating Income-$55,119,000N/M
Operating Cash Flowderived-$36,210,000N/M
Free Cash Flowderived-$36,939,000N/M
Margins · derived
Operating margin-805.8%−186.2 pt vs Q2 2013

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2014Q2 2013Q2 2012Q2 2011
Revenue$6.84M$9.66M$14.60M$11.26M
Net Income———-$18.84M
EPS Diluted-$0.44-$0.57-$0.38-$0.19

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR